NovAccel
NovAccel is developing a superconducting accelerator for the production of medical isotopes, including Actinium-225.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredAug 25, 2024 (2 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | — |
Timeline
- Website created
Founders and team
SY
Satoru Yamashita Founder
Companies like NovAccel
SStandardX$13.28M Seed · Sep 2026
TTibaRaySeed · Nov 2026
FFuriosaAI$620M Series B+ · Oct 2026
RRebellions$400M Series B+ · Mar 2026
AAkeana$100M · Aug 2024
EEnCharge AISeries B+ · Sep 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/novaccel (get a free API key).